456 related articles for article (PubMed ID: 22210656)
1. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
[TBL] [Abstract][Full Text] [Related]
2. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
[TBL] [Abstract][Full Text] [Related]
4. BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
Quartuccio L; Salvin S; Fabris M; Maset M; Pontarini E; Isola M; De Vita S
Rheumatology (Oxford); 2013 Feb; 52(2):276-81. PubMed ID: 22879463
[TBL] [Abstract][Full Text] [Related]
5. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection.
Ambrosetti A; Zanotti R; Pattaro C; Lenzi L; Chilosi M; Caramaschi P; Arcaini L; Pasini F; Biasi D; Orlandi E; D'Adda M; Lucioni M; Pizzolo G
Br J Haematol; 2004 Jul; 126(1):43-9. PubMed ID: 15198730
[TBL] [Abstract][Full Text] [Related]
6. [Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: preliminary data].
Logvinenko OA; Vasil'ev VI; Sedyshev SKh; Safonova TN; Rodionova EB; Kokosadze NV; Aleksandrova EN; Cherkasova MV; Radenska-Lopovok SG; Nasonov EL
Ter Arkh; 2012; 84(12):88-96. PubMed ID: 23479998
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
8. Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome.
De Vita S; Dolcetti R; Ferraccioli G; Pivetta B; De Re V; Gloghini A; D'Agosto A; Bartoli E; Carbone A; Boiocchi M
J Rheumatol; 1995 Sep; 22(9):1674-80. PubMed ID: 8523344
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
[TBL] [Abstract][Full Text] [Related]
10. Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering.
Gasparotto D; De Vita S; De Re V; Marzotto A; De Marchi G; Scott CA; Gloghini A; Ferraccioli G; Boiocchi M
Arthritis Rheum; 2003 Nov; 48(11):3181-6. PubMed ID: 14613281
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
[TBL] [Abstract][Full Text] [Related]
12. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
13. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer.
Ramos-Casals M; De Vita S; Tzioufas AG
Autoimmun Rev; 2005 Jan; 4(1):8-15. PubMed ID: 15652773
[TBL] [Abstract][Full Text] [Related]
15. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
16. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.
Saadoun D; Landau DA; Calabrese LH; Cacoub PP
Rheumatology (Oxford); 2007 Aug; 46(8):1234-42. PubMed ID: 17566058
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
19. Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis.
Quartuccio L; Isola M; Corazza L; Maset M; Monti G; Gabrielli A; Tzioufas AG; Ferri C; Ferraccioli G; Ramos-Casals M; Voulgarelis M; Lenzi M; Mascia MT; Sansonno D; Cacoub P; Tomsic M; Tavoni A; Pietrogrande M; Zignego AL; Scarpato S; Pioltelli P; Steinfeld S; Lamprecht P; Galli M; Bombardieri S; De Vita S
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S48-52. PubMed ID: 22410397
[TBL] [Abstract][Full Text] [Related]
20. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
